Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000
Reexamination Certificate
active
07094799
ABSTRACT:
A new polymorphic crystalline form of bicifadine hydrochloride, designated form B, which is more thermodynamically stable than the previously known polymorphic form of bicifadine hydrochloride, designated as form A, methods for preparing said crystalline form B and pharmaceutical compositions containing said crystalline form B.
REFERENCES:
patent: 4196120 (1980-04-01), Fanshawe et al.
patent: 4231935 (1980-11-01), Fanshawe et al.
patent: 4435419 (1984-03-01), Epstein et al.
patent: 4504657 (1985-03-01), Bouzard et al.
patent: 4521431 (1985-06-01), Crookes
patent: 6204284 (2001-03-01), Beer et al.
Nicholas D. Cheronis, 1958, “Semicro Experimental Organic Chemistry”, Chapter 5.
Brittain, H. G., polymorphism in Pharmaceutical Solids, Drugs and the Pharmaceutical Science; 1999, V. 95, pp. 348-361.
Halloran Kevin John
Russell Brenton William
Shipplett Rex Alwyn
Black Lowe & Graham PLLC
DOV Pharmaceutical, Inc.
King Jeffrey J.
Saeed Kamal A.
Shiao Robert
LandOfFree
Polymorphs of bicifadine hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphs of bicifadine hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of bicifadine hydrochloride will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646670